Second-opinion pathology review
A re-read of your tissue slides and pathology report by another specialist pathologist, often used for rare, unusual or borderline diagnoses to check the findings before treatment.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Another specialist re-reads your existing slides and report — there is usually no new procedure for you.
- It is most valuable for rare, unusual or borderline cases, and is a routine part of care for some conditions.
- A review often confirms the original diagnosis; sometimes it refines or changes it, which can affect treatment.
- It does not replace your treating team, who still discuss and plan your care with you.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Adds the view of a pathologist with particular expertise in your type of disease
The diagnosis is already clear and a review would not change your treatment.
Your hospital locates and sends the slides, blocks and original report to the reviewing specialist. You usually carry on as normal.
A clear explanation of whether the diagnosis is confirmed, refined or changed, and why.
Your hospital locates and sends the slides, blocks and original report to the reviewing specialist. You usually...
A review often takes from a few days to a couple of weeks once the material arrives, longer if extra tests are...
The reviewing pathologist's report goes to your team and is often discussed at an MDT meeting.
Your treating team explains whether the diagnosis is confirmed, refined or changed, and what it means for your...
What is a second-opinion pathology review?
A second-opinion pathology review means that another specialist pathologist looks again at the slides from your biopsy or operation, and at the original report, to confirm or refine the diagnosis. It uses the sample that has already been taken — it is not a new procedure on you.
It is most useful for cancers and other conditions that are rare, unusual, or hard to classify, where a small difference in interpretation can change treatment. Reviews are often done by a pathologist who specialises in that particular type of disease, and are a normal, built-in part of care for some conditions rather than a sign that anything has gone wrong.
A review can confirm the original diagnosis, refine the detail, or occasionally differ from it. It is a careful check by another expert, not a replacement for your treating team, who still plan your care with you.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Options at a glance
These are the main approaches described in this guide. The right option depends on the diagnosis, your goals and what your clinician thinks is safe.
Routine central review
For some rare or complex cancers, slides are sent to a specialist centre as a built-in step, sometimes before an MDT meeting, so an expert re-reads them as standard.
Referral for a difficult or borderline case
Your own pathologist may send the slides to a colleague with extra expertise when a diagnosis is unusual, uncertain or borderline.
Patient-requested second opinion
You can ask your team about a second opinion if you have concerns; they can usually arrange for the slides and report to be reviewed by another specialist.
Review with extra tests
The reviewing pathologist may request additional stains or molecular tests on the existing sample to help reach or confirm a diagnosis.
Preparing for your test
- The review uses slides and tissue blocks you have already given, so you usually do not need to do anything.
- Ask your team whether a review is being arranged, why, and roughly how long it will take.
- If you are requesting one, ask your treating team how to go about it rather than approaching a laboratory directly.
- Bring or mention the original report and where the biopsy or operation took place, to help locate the slides.
- Ask whether your treatment will continue, wait, or change while the review happens.
- Ask who will explain the outcome to you and what the possible results are.
What happens
There is no appointment or procedure for you. Your hospital sends the existing slides, tissue blocks and the original report to another specialist pathologist — often one who concentrates on that type of disease, sometimes at a larger centre.
The reviewing pathologist examines the slides under the microscope, considers the original report, and may ask for extra stains or molecular tests on the stored tissue. They then write their own report, which goes back to your team and is often discussed at a multidisciplinary team (MDT) meeting.
Your treating team brings the review together with your scans and overall picture, and explains what it means for your diagnosis and treatment.
Is this test right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- The diagnosis is already clear and a review would not change your treatment.
- There is not enough good-quality tissue to give a more confident opinion, so a fresh sample may be needed first.
- Urgent treatment cannot safely wait for a review.
- You are seeking a clinical opinion on treatment rather than a re-read of the slides, which is a different kind of second opinion.
Delay or rearrange if…
- The original slides or blocks cannot yet be located or are in short supply.
- Extra tests on the sample are still being done.
- Your treatment is time-critical and your team advises starting first.
- You have not yet had the original report explained to you.
Alternatives to discuss
- Accepting the original report where the diagnosis is clear and agreed.
- Discussion at an MDT without a separate central review.
- Extra stains or molecular tests on the existing sample instead of a full re-read.
- A new biopsy if the existing material cannot give a confident answer.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Adds the view of a pathologist with particular expertise in your type of disease
- Can confirm the original diagnosis and give reassurance before treatment
- Can refine the diagnosis or grade, which may change the recommended treatment
- Can pick up rare or borderline features that are easy to miss
- Supports careful, shared decision-making for unusual or difficult cases
Risks & complications
- A short delay while slides are sent and reviewed
- Anxiety while you wait for the outcome
- The review confirms the original diagnosis, so nothing changes
- The review differs from the original report, which can be unsettling even when helpful
- Extra tests on the stored sample are needed, adding a little more time
- The two specialists still cannot be fully certain, and the case stays difficult
- The original slides or blocks are hard to locate or in short supply, delaying review
- A repeat biopsy is suggested because the existing material is not enough for a confident opinion
A review is a normal safeguard for difficult cases, not a criticism of anyone. The main downside is a short delay and the uncertainty of waiting. Ask your team why a review is being done, how long it will take, whether your treatment should wait, and what each possible outcome would mean.
Published figures to discuss
How often a second opinion changes a diagnosis depends heavily on the type of disease and how it was selected for review — figures from specialist centres reflect cases chosen because they are difficult, and do not apply to ordinary, clear-cut diagnoses. We therefore describe this in words rather than giving a single percentage, and your team can explain how likely a change is in your situation.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Diagnosis or grade changes on review | Uncommon but clinically important | Specialist review can alter tumour type, grade, margins or biomarker interpretation. | Guide sourcesClinical context |
| Review limited by slide/block availability | Practical issue | Original slides, blocks, reports and clinical context are needed for a meaningful opinion. | Guide sourcesClinical context |
| Treatment delayed while review occurs | Clinical balancing issue | Second opinion should be prioritised when it may change treatment, without missing urgent windows. | Guide sourcesClinical context |
| Different wording mistaken for disagreement | Common | Specialists may use different phrasing while reaching the same practical management conclusion. | Guide sourcesClinical context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no physical recovery, because the review is done on a sample you have already given. 'Afterwards' is about waiting for the reviewing pathologist's report and understanding it with your team.
- Feeling anxious while you wait for the outcome
- A short delay while slides are sent and reviewed
- Being told the original diagnosis is confirmed
- Being told extra stains or tests are being done on the existing sample
Aftercare
- Ask for the outcome to be explained clearly, including whether anything has changed.
- If the review differs from the original report, ask what this means for your treatment and why.
- Keep a note of both reports for your records and any future opinions.
- Ask whether the case has been or will be discussed at an MDT meeting.
- Ask whether any further test or, rarely, a new sample is needed.
- Check who to contact if you have questions after your results conversation.
- Reason the review is being done
- Where the slides are being sent and roughly how long it will take
- Whether treatment continues or waits meanwhile
- Who will explain the outcome to you
- A copy or summary of both reports for your records
- A contact for questions
⚠ Get urgent help if…
- New or worsening symptoms while you wait — contact your team rather than waiting for the review
- Feeling unable to cope with the wait or with uncertain news — ask for support from your team or clinical nurse specialist
- Being asked to start a major treatment before a planned review is back — ask whether it can safely wait
- Hearing nothing about an expected review after the time your team gave you — chase it up
- Being told to pay privately for a review your NHS team has not advised — ask your team first
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A review that confirms the original diagnosis can be reassuring and lets treatment go ahead with more confidence. A review that refines or changes the diagnosis can be unsettling, but it is the point of asking another expert: it may lead to a more suitable treatment plan.
Sometimes even two specialists cannot be completely certain, particularly with very rare or borderline conditions. In that case your team will explain the uncertainty honestly and plan with you, sometimes with further tests or close follow-up.
A second-opinion report relates to the slides and sample reviewed at that time. If your situation changes, or new tissue is taken later, the picture may need looking at again. The review forms part of your permanent record and can be referred to in future care.
Related tests, treatments or support
A second-opinion review is usually read alongside the original report, your scans and your overall health, most often at an MDT meeting. It may be combined with extra stains or molecular tests on the existing sample to reach a confident diagnosis.
Follow-up & long-term care
The reviewing pathologist's report goes back to your treating team and is commonly discussed at an MDT meeting. Your team then explains whether the diagnosis is confirmed, refined or changed, and arranges any next steps, such as adjusting treatment, doing further tests, or, rarely, taking a fresh sample.
- Keep copies of both pathology reports for future care or opinions.
- If the diagnosis was uncertain, ask what follow-up or repeat assessment is planned.
- If a further opinion is ever needed, your team can usually arrange for the same material to be reviewed again.
Repeat, follow-on and what comes next
- A review may confirm, refine or change the original diagnosis.
- Extra stains or molecular tests on the existing sample are sometimes needed before an opinion is final.
- Rarely, the existing material is not enough and a fresh sample is suggested.
- Very rare or borderline cases may remain uncertain even after expert review.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear explanation of whether the diagnosis is confirmed, refined or changed, and why.
- Discussion at an MDT, with both reports available to your team.
- A named contact for your questions about the outcome.
- A plan for further tests or, rarely, a fresh sample if the case is still uncertain.
- Honest acknowledgement of any remaining uncertainty and how it will be managed.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- The reviewing specialist's fee for examining the slides and writing a report.
- Whether extra stains or molecular tests are needed on the existing sample.
- Locating, preparing and transporting the original slides and tissue blocks.
- Any consultation to explain the outcome and plan treatment.
- Whether the review is part of an NHS pathway or arranged privately.
- The reviewing pathologist's fee and what the report will cover.
- The cost of any extra stains or molecular tests on the existing sample.
- Any fee for retrieving and sending the original slides and blocks.
- The consultant fee to explain the outcome and plan next steps.
- Expected turnaround time and what happens if the material is inadequate.
- Whether the same review could be arranged on the NHS through your team.
On the NHS? A specialist second-opinion review is commonly arranged on the NHS for rare or difficult cases, often as part of MDT care; you can also ask your team about a review if you have concerns.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Not being told why a review is being done, leaving you fearing an error.
- Not being warned that a review may change as well as confirm the diagnosis.
- No clear plan for whether treatment waits while the review happens.
- Approaching a private laboratory directly instead of through your treating team.
- No clear explanation of who will discuss the outcome with you.
Marketing red flags
- Suggesting every patient needs a paid second opinion regardless of how clear the diagnosis is.
- Promising a review will deliver 'better news' or a different answer.
- Bypassing your treating team rather than working with them.
- Quoting how often opinions change without explaining that those figures come from difficult, selected cases.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- Why is a second-opinion review being done in my case?
- Who will review the slides, and do they specialise in this type of disease?
- How long will it take, and should my treatment wait?
- What are the possible outcomes, and what would each mean for me?
- What happens if the two opinions differ?
- Will my case be discussed at an MDT, and who will explain the result to me?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my test, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this test not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Can I get a second-opinion pathology review on the NHS?
Does a review mean my pathologist got it wrong?
Do I need another biopsy for a review?
How long does a review take?
What if the second opinion disagrees with the first?
Does the review replace my treating team?
Find a verified specialist for second-opinion pathology review
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: Royal College of Pathologists — Histopathology Royal College of Pathologists — Cancer datasets and tissue pathways Cancer Research UK — Biopsy Macmillan Cancer Support — Biopsy Macmillan Cancer Support — Rare cancers NHS — Biopsy
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Histology results consultation · Cancer multidisciplinary team (MDT) review · Specialist subspecialty pathology reporting · Molecular and genetic tumour testing · Biopsy analysis (tissue diagnosis)